HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Relationship of different platelet response criteria and patient outcomes in a romiplostim myelodysplastic syndromes trial.

AuthorsU Platzbecker, M A Sekeres, H Kantarjian, A Giagounidis, G J Mufti, C Jia, A S Yang, P Fenaux
JournalLeukemia (Leukemia) Vol. 28 Issue 12 Pg. 2418-21 (Dec 2014) ISSN: 1476-5551 [Electronic] England
PMID25179731 (Publication Type: Clinical Trial, Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Receptors, Fc
  • Recombinant Fusion Proteins
  • Thrombopoietin
  • romiplostim
Topics
  • Humans
  • Myelodysplastic Syndromes (blood, complications, mortality)
  • Platelet Count
  • Receptors, Fc (therapeutic use)
  • Recombinant Fusion Proteins (therapeutic use)
  • Thrombocytopenia (drug therapy, etiology, mortality)
  • Thrombopoietin (therapeutic use)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: